Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Atherosclerosis

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ATHEROSCLEROSIS.2006.12.010PMID 17222847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.

  2007cited by this paper
• Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family.

  2007cited by this paper
• Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia Published, JLR Papers in Press, July 21, 2006.

  2006cited by this paper
• The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II

  2006cited by this paper
• A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia.

  2006cited by this paper
• APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.

  2006cited by this paper
• Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein Lipase*

  2005cited by this paper
• Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants

  2005cited by this paper
• Apolipoproteins C-III and A-V as Predictors of Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B-100 Kinetics

  2005cited by this paper
• Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

  2005cited by this paper
• Determination of the Functionality of Common APOA5 Polymorphisms*

  2005cited by this paper
• Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

  2005cited by this paper
• The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk

  2005cited by this paper
• Apolipoprotein A-V-heparin Interactions

  2005cited by this paper
• Give me A5 for lipoprotein hydrolysis!

  2005cited by this paper
• The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.

  2005cited by this paper
• Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

  2004cited by this paper
• Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia

  2004cited by this paper
• ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis*

  2004cited by this paper
• The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

  2004cited by this paper
• Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

  2002cited by this paper
• Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

  2002cited by this paper
• The apoAI-CIII-AIV gene cluster.

  2001cited by this paper
• Apolipoprotein A-V

  2001cited by this paper
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

  2001cited by this paper

• The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis

  2024cites this paper
• Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye.

  2023cites this paper
• Genetic assessment using whole-exome sequencing for a young hypertriglyceridemic patient with repeated acute pancreatitis.

  2022cites this paper
• Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine

  2022cites this paper
• Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency

  2019cites this paper
• Dysrégulations de la production et de la clairance des lipoprotéines riches en triglycérides

  2018cites this paper
• Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels

  2018cites this paper
• Régulation épigénétique de la lipolyse intravasculaire des triglycérides

  2015cites this paper
• Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant.

  2014cites this paper
• Triglyceride Level Affecting Shared Susceptibility Genetic Variants in Type 2 Diabetes Mellitus

  2013influential citation
• Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

  2013cites this paper
• Lipoprotein and Lipid Metabolism

  2013cites this paper
• APOA5 Q97X Mutation Identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family

  2012influential citation
• Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion[S]

  2011cites this paper
• Apolipoprotein A-V; a potent triglyceride reducer.

  2011cites this paper
• The Chylomicron: Relationship to Atherosclerosis

  2011cites this paper
• The relative importance of common and rare genetic variants in the development of hypertriglyceridemia

  2011cites this paper
• Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

  2011cites this paper
• [Genetics of ischemic stroke: where are we now?].

  2011cites this paper
• Genetic architecture of circulating lipid levels

  2011cites this paper
• Genetic determinants of plasma triglycerides

  2011cites this paper
• Cloning, Expression, Purification and Polyclonal Antibody Preparation of Human Apolipoprotein A5: Cloning, Expression, Purification and Polyclonal Antibody Preparation of Human Apolipoprotein A5

  2010cites this paper
• Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood

  2010cites this paper
• Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned

  2010cites this paper
• The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

  2010cites this paper
• Genetics of metabolic syndrome and related traits

  2010cites this paper
• Recherche de déterminants génétiques des phénotypes associés au syndrome métabolique en population

  2009cites this paper
• Plasma lipoproteins: genetic influences and clinical implications

  2009cites this paper
• Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.

  2009cites this paper
• A novel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient.

  2009cites this paper
• Apolipoproteins A-I and A-V as gene therapeutic targets to intervene in lipid metabolism

  2009cites this paper
• Lipoproteins: Genetic Disorders

  2009cites this paper
• The Ins and Outs of Adipose Tissue

  2009cites this paper
• Effects of Six APOA5 Variants, Identified in Patients With Severe Hypertriglyceridemia, on In Vitro Lipoprotein Lipase Activity and Receptor Binding

  2008cites this paper
• Gen de la apolipoproteína A5: asociación con el metabolismo de los triglicéridos y las enfermedades cardiovasculares

  2008cites this paper
• Apolipoprotein AV: gene expression, physiological role in lipid metabolism and clinical relevance

  2008cites this paper
• APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia

  2008cites this paper
• APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

  2008cites this paper
• [Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease].

  2008cites this paper
• Apoprotein A-V: An important regulator of triglyceride metabolism

  2008cites this paper
• ApoA5: Ein wichtiger Regulator der Triglyzeride oder nur ein weiteres Apoprotein?

  2008cites this paper
• Apolipoprotein A5: an emerging paradigm for genetic associations and interactions in lipoprotein and cardiovascular research

  2007cites this paper
• Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient

  2007cites this paper
• Fibrates Apolipoprotein A-V Genetic Variation and Plasma Lipoprotein Response to

  2007cites this paper
• Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.

  2007cites this paper
• Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650)

  2007cites this paper